INTRODUCTION
Prolonged or repeated acute convulsive seizures are regarded as medical emergencies in both children and adults. Uncontrolled, such seizures may progress to status epilepticus carrying an increased risk of morbidity (for example, severe cerebral damage) and mortality; 1-2 their early treatment may prevent such consequences. Prolonged acute seizures may occur in the dental practice 3 and dental practitioners should be able to manage and treat them appropriately.
The National Institute for Health and Clinical Excellence (NICE) has recently published updated guidance on the management of prolonged convulsive seizures, recommending the administration of buccal midazolam as first-line treatment in children and adults with prolonged (>5 minutes) or repeated (more than three in a hour) seizures in the community. 4 The Resuscitation Council (UK) has also recently updated their guidance on the use of buccal midazolam for seizure treatment in the dental practice. 5 This article is published in response to a query from reader Sarah Clements, based at Golding House Dental Practice Ltd in Kent, regarding the BDJ paper entitled 'Updated guidance on medical emergencies and resuscitation in the dental practice' (BDJ 2012; 212: 41-43). Sarah wished to be provided with further clarification on the ordering, prescribing and administration of midazolam.
has a shelf life of 18 months. It is available as a 5 mg/ml solution for use in children up to 18 years. Its use in adults remains 'off-label' but the Resuscitation Council (UK) recommends a 10 mg (2 ml) dose for adults (as for the older child) and considers that such 'off-label' use of a licensed product is justified in the emergency situation. 5 In both 'licensed' and 'off-label' settings, the drug does not need to have been prescribed to the patient when used in an emergency. In the dental practice, it should, however, be administered by (or under the supervision of) a dental practitioner.
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PROCEDURE FOR ADMINISTERING BUCCOLAM®
• Select appropriate age-specific dose for the patient ( • Provides an update on the stocking and administration of Buccolam® in the dental practice.
• Highlights the reclassification of midazolam as a Schedule 3 controlled drug. 
I N B R I E F GENERAL
GENERAL
• Remove the syringe cap (do not attach a needle to the syringe: Buccolam® must not be injected) • Carefully and slowly advance the syringe into the space between the gum and the cheek and insert the Buccolam® liquid (for larger volumes of Buccolam® and/or smaller patients, it is recommended to slowly insert half into one side of the mouth and the other half into the other side) • Show the empty syringe to the paramedics once they arrive so they know what dose has been administered.
Only administer a single dose of Buccolam® (if the seizure has not stopped within ten minutes after its administration, if not done already, call 999 for an ambulance).
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RECLASSIFICATION OF MIDAZOLAM AS A SCHEDULE 3 CONTROLLED DRUG
Concerns have been raised regarding the recent reclassification of midazolam as a 'Schedule 3' controlled drug. Although this reclassification does require certain legal processes, there is no legal requirement for midazolam to be stored in a locked cupboard nor to maintain a midazolam controlled drug register.
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ORDERING STOCKS OF MIDAZOLAM
Concerns have also been raised regarding the ordering of stocks of midazolam for use in the emergency treatment of seizures. A dentist can issue a requisition for any licensed product for use within their practice, as appropriate, using the standardised requisition form: FP10CDF. 5 Dentists who do not use midazolam on a regular basis can still requisition this Schedule 3 drug under the conditions laid out by the Royal Pharmaceutical Society of Great Britain in their guidance Medicines, ethics and practice: the professional guide for pharmacists.
